This "boring" drugmaker could gain as much as 76% as biotech sector bounces back
TheStreet.com / Posted 27 days ago
Provigil and Nuvigil for narcolepsy and other sleep disorders, and Azilect for Parkinson's disease. It also offers Treanda for the treatment of leukemia and lymphoma.
In a coup, the company last year was granted a federal Orphan Drug... Read more